Angela C Rutledge - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Angela C Rutledge

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Cancer Cell|November 19, 2011

Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemiaMarko Skrtić, Shrivani Sriskanthadevan, Bozhena Jhas, et al.

Clinical Biochemistry|May 23, 2025

Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient careDaniel R Beriault, Yu Chen, Paul Yip, et al.

The Journal of Clinical Investigation|December 4, 2012

Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitorsMahadeo A Sukhai, Swayam Prabha, Rose Hurren, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Cancer Cell|November 19, 2011

Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemiaMarko Skrtić, Shrivani Sriskanthadevan, Bozhena Jhas, et al.

Clinical Biochemistry|May 23, 2025

Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient careDaniel R Beriault, Yu Chen, Paul Yip, et al.

The Journal of Clinical Investigation|December 4, 2012

Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitorsMahadeo A Sukhai, Swayam Prabha, Rose Hurren, et al.

Pageof 3